Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday, 12th Nov, 2026 to transact the business as given below: 1. To Consider and approve ....

08.11.2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Dear Sir/Madam, Scrip Code: 539428 Sub: Intimation of Board Meeting under Regulation 29 of SEBI (LODR) Regulations, 2015 and Closure of Trading Window Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday, 12th November, 2026 at Shop No 1 Building Name:Shivprasad Harihar Singh Compound, Block Sector:Jogeshwari East, Road: Caves Road. Pratap Nagar -Mumbai, Maharashtra, 400060 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th September 2026. 2. Any other matter with the permission of the Chair. Further, in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation, 2015 and in compliance of the circular no. LIST/COMP/ 01/2019-20 issued by BSE Limited on 02ndApril, 2019, intimation for the closure of trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 26th September, 2026 till expiry of 48 hours after the declaration of Un- audited financial results of the Company for the quarter ended 30th September 2026. This is for your information and record. Thanking you. For Tejnaksh Healthcare Limited Dr. Ashish V. Rawandale Managing Director DIN:- 02005733